The Evolution of the Developmental Therapeutics Program (DTP)
The Evolution of the Developmental Therapeutics Program (DTP)
For over 50 years, DTP has helped transform scientific discoveries into treatments that have improved patient outcomes. Current DCTD Director, James H. Doroshow, M.D., F.A.C.P., and former program leaders, reflect on DTP's role in public-interest cancer drug development